
- Volume 0 0
WIDER COPAY DIFFERENTIALS PROMOTE GENERIC DISPENSING
A new study by researchers at Express Scripts has confirmeda connection between the copay differentials forbrand and generic drugs set by drug plans and the willingnessof patients to use lower-cost generic medicines. According tothe study, plans with a generic versus brand copayment differentialof $21 or more used generic drugs at a rate 5.2%higher than those with a differential of $5 or less.
?The findings in this study show that getting plan designright pays off, given that a 1% increase in generic use resultsin an estimated 1.6% decrease in total drug-plan costs,? aspokesman for the researchers said. The study, published inthe June 2007 issue of the American Journal of Managed Care,also found that plans with $16 to $20 differentials used genericdrugs at rates that were 2.9% higher than those with thelowest differential between generic and brand copayments.
Articles in this issue
over 18 years ago
Calming the Symptoms of Menopauseover 18 years ago
Zoster Vaccineover 18 years ago
pharmacy TECHNOLOGY productsover 18 years ago
health-systems PRODUCT newsover 18 years ago
can you READ these Rxs?over 18 years ago
can you READ these Rxs?over 18 years ago
Generic Times Product Newsover 18 years ago
compounding HOTLINEover 18 years ago
Human HRT Leads Compounding Renaissanceover 18 years ago
Prescription-overdose Deaths Surpass Car-accident DeathsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.




































































































































































































